Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

albert_bourla2019_300x170_1

Pfizer CEO Albert Bourla to Succeed Ian Read as Executive Chairman

September 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer’s executive chairman Ian Read, is to be succeeded by CEO Albert Bourla with a date to start the post …
Appointment
shutterstock

The world needs a better plan for cancer survival by 2030

September 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Roche, UN General Assembly, United Nations, feature, opinion, pharma

Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

Another week comes to a close, and it’s time to review the biggest stories of the week. Check out the …
News
Catapult Stevenage site

Cell and Gene Therapy Catapult doubles capacity at UK site

September 26, 2019 Manufacturing and Production, Medical Communications

The United Kingdom’s Cell and Gene Therapy Catapult (CGT Catapult) has added six additional modules of cleanroom space at its …
News

Iran reveals plans to domestically produce 135 strategic drugs

September 26, 2019 Manufacturing and Production Iran, pharma, production

Iran has announced plans to promote self-sufficiency within the country with regard to its medicines production, with an aim of …
News
Ipsen Logo

Ipsen announces positive phase 3 results in limb spastic hemiparesis

September 24, 2019 Manufacturing and Production, Research and Development

Ipsen has announced results from its ENGAGE study for the combination of Dysport (abobotulinumtoxinA) alongside Guided Self-rehabilitation contracts (GSC) which …
News
celltrion1

Celltrion’s subcutaneous infliximab biosimilar secures CHMP recommendation

September 24, 2019 Manufacturing and Production, Sales and Marketing EMA, EU, Europe, biosimilar, celltrion, infliximab, pharma

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to Celltrion’s CT-P13 SC, the subcutaneous …
News
Takeda HQ

Evotec and Takeda enter into multi therapeutic area collaboration

September 24, 2019 Manufacturing and Production, Research and Development

Evotec have announced a strategic, multi-year drug discovery collaboration with Takeda, with both companies aiming to establish at least five …
News

Bayer’s Vitravki becomes first EU-approved tumour-agnostic therapy

September 24, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Cancer, Vitravki, pharma

Bayer has announced that its tyrosine receptor kinase (TRK) inhibitor Vitrakvi (larotrectinib) has scored approval from the European Commission for …
News
images

Medicinal cannabis product Epidyolex approved in EU for childhood epilepsy

September 24, 2019 Manufacturing and Production, Research and Development

GW Pharmaceuticals, a world leader in the development of cannabinoid prescription drugs has announced it has received approval from the …
News

Destiny Pharma’s Joe Eagle to step down from Board

September 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs to address the global crisis …
Appointment

Living with acute myeloid leukaemia

September 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute myeloid leukaemia, feature, patient experience, pharma

Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his …
Feature
appg

New APPG report on access to cutting edge medicines

September 17, 2019 Manufacturing and Production

A new report from the All-Party Parliamentary Groups (APPG) is urging the life science community to work together to speed …
News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
Appointment
common cold

New experimental approach could stop common cold

September 17, 2019 Manufacturing and Production, Research and Development

Scientists believe they may have found a way to stop the common cold as instead of attacking the virus directly, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026